|
|
|
 |
|
|
 |
 |
Endo Pharmaceuticals Holdings Incorporation
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Endo Pharmaceuticals Holdings Incorporation. The Group's principal activity is to conduct research, develop, sale and market branded and generic prescription pharmaceuticals used primarily to treat and manage pain. It markets branded pharmaceutical products to drug wholesalers, pharmacies, hospitals, governmental agencies, physicians and other healthcare professionals. It uses a sales force of approximately 590 sales representatives in the United States to market its pharmaceutical products. The Group's marketed products include Lidoderm(R), Percocet(R), Percodan(R), Zydone(R), Frova(R) (1), DepoDur(R) (2), Endocet(R), Morphine Sulfate ER, Oxycodone ER. The Group contracts with third parties to provide certain critical services such as manufacturing, warehousing, distribution, customer service, financial functions, certain research and development activities and medical affairs. As on 23-Feb-2009, it acquired Indevus Pharmaceuticals Inc.
|
|
| |
Wright Quality Rating:
BAA1 Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/5/2010):
19.57
(Figures in
U.S. Dollars) |
|
1 Week |
-2.7% |
|
13 Weeks |
-4.1% |
|
|
|
|
|
|
|
|
|
4 Weeks |
-14.9% |
|
52 Weeks |
-16.8% |
|
|
|
| |
| |
Endo Pharmaceuticals Holdings Incorporation
Key Data: |
|
|
|
| |
Ticker: |
ENDP |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
NAS |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Ethical Drug Manufacturers |
| |
|
| |
2008
Sales |
1,260,536,000
(Year Ending Jan 2009). |
Employees: |
1,216 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
2,294,763,229 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
117,259,235 |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
17,067,885 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Endo Pharmaceuticals Holdings Incorporation, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Endo Pharmaceuticals Holdings Incorporation company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Endo Pharmaceuticals Holdings Incorporation Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Endo Pharmaceuticals Holdings Incorporation
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Endo Pharmaceuticals Holdings Incorporation Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|